Singapore: Dr Anna Lavelle, CEO, AusBiotech, has been elected to Fellowship of the Australian Academy of Technological S...
Singapore: Australia's healthcare company focused on investing in and developing next generation technologies, Admedus, ...
With 11 percent share and $11.65 billion is revenue, Australia grew marginally. It has been a bad year or Australia's...
Singapore: Australia-based Mayne Pharma has struck a deal to acquire Doryx acne-treatment brand and assets in the US for...
Singapore: Australia's regenerative medicine company, Orthocell, has recieved Chinese patent for its Collagen Scaffold f...
Singapore: Serum Institute of India (SII) has applied for permits to export flu vaccines produced using Australia's BioD...
Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...
The press release indicated that Immutep is a French company and is a 100 percent subsidiary of Prima BioMed. Immutep de...
Singapore: Melbourne-based Phosphagenics has resolved all crystallisation issues associated with its opioid patch devel...
Singapore: In July 2013, Therapeutics Goods Administration, Australia, had published a guidance on biosimlar naming base...
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appe...
Singapore: US-based AirStrip recently inked a pact with Life Monitor, a subsidiary of Cardioscan, to sell AirStrip solut...
Singapore: Australian government has recently made an announcement that parents who refuse to vaccinate their children m...
One of the challenges in the R&D of next generation vaccines is the development of a delivery technology that will b...
When we talk about vaccines, most people think of an injection to prevent childhood infectious disease. However, in rece...
Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...
Singapore: Australia's QRxPharma has collaborated with Canadian specialty pharmaceutical company, Paladin Labs on licens...
